Table 2.
Demographics of the two groups.
| CH (n = 17) | SH (n = 13) | P value | |
|---|---|---|---|
| Sex (male : female) | 11 : 6 | 10 : 3 | 0.46 |
| Age (years) | 67.1 ± 7.0 | 71.1 ± 7.3 | 0.14 |
| Height (cm) | 160.0 ± 8.5 | 160.0 ± 7.6 | 0.93 |
| Weight (kg) | 51.5 ± 8.5 | 56.2 ± 10.7 | 0.20 |
| BSA (m2) | 1.51 ± 0.15 | 1.57 ± 0.17 | 0.43 |
| Type of disease | |||
| Gastric cancer | 14 | 5 | |
| Urothelial cancer | 2 | 5 | |
| Lung cancer | 1 | 3 | |
| Combined with | |||
| TS-1 | 14 | 5 | |
| Gemcitabine | 2 | 5 | |
| Capecitabine | 1 | ||
| Irinotecan | 1 | ||
| Etoposide | 1 | 1 | |
| Cr (mg/dL) | 0.71 ± 0.19 | 0.83 ± 0.27 | 0.32 |
| CCr (mL/min) | 73.2 ± 19.3 | 68.5 ± 25.1 | 0.39 |
Values are mean ± SD.
CH: continuous hydration.
SH: short hydration.
BSA: body surface area.
Cr: creatinine.
CCr: creatinine clearance.